Ovarian Cancer

Ovarian Cancer | Unmet Need | US/EU | 2017

Platinum-based chemotherapy has remained the standard of care for the treatment of platinum-sensitive ovarian cancer, but new classes of drugs such as angiogenesis inhibitors and more recently…

Ovarian Cancer | Pharmacor | G7 | 2015

The ovarian cancer therapy market retains its potential for commercial reward for drug developers. Although the disease tends to respond well initially to chemotherapy and current drug treatment…